In today’s recent session, 0.39 million shares of the Oncology Institute Inc (NASDAQ:TOI) have been traded, and its beta is 0.34. Most recently the company’s share price was $1.12, and it changed around $0.12 or 12.43% from the last close, which brings the market valuation of the company to $84.62M. TOI at last check was trading at a discount to its 52-week high of $1.89, offering almost -68.75% off that amount. The share price’s 52-week low was $0.13, which indicates that the recent value has risen by an impressive 88.39% since then. We note from Oncology Institute Inc’s average daily trading volume that its 10-day average is 0.29 million shares, with the 3-month average coming to 768.68K.
Oncology Institute Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended TOI as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Oncology Institute Inc is expected to report earnings per share of 0 for the current quarter.
Oncology Institute Inc (NASDAQ:TOI) trade information
Instantly TOI has been showing a green trend so far today with a performance of 12.43% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.1400 on recent trading dayincreased the stock’s daily price by 1.75%. The company’s shares are currently up 262.46% year-to-date, but still up 59.77% over the last five days. On the other hand, Oncology Institute Inc (NASDAQ:TOI) is 25.86% up in the 30-day period. We can see from the shorts that 1.07 million shares have been sold at a short interest cover period of 1.36 day(s).
The consensus price target as assigned by Wall Street analysts is $8, which translates to bulls needing to increase their stock price by 86.0% from its current value. Analyst projections state that TOI is forecast to be at a low of $6 and a high of $10.
Oncology Institute Inc (NASDAQ:TOI)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 14.87% of Oncology Institute Inc shares, and 40.04% of them are in the hands of institutional investors. The stock currently has a share float of 47.03%. Oncology Institute Inc stock is held by 40.0 institutions, with FMR LLC being the largest institutional investor. By 2024-06-30, it held 6.4005% of the shares, which is about 4.75 million shares worth $2.19 million.
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), with 4.5263% or 3.36 million shares worth $1.55 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Dec 31, 2024. The former held 1.27 shares worth $1.46 million, making up 1.68% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 422.98 shares worth around $0.49 million, which represents about 0.56% of the total shares outstanding.
